Publications from the group
Links to selected publications in:
News from the group
Additional establishments of the group
Department of Selenoprotein Research
Elias Arnér's laboratory at the National Institute of Oncology, Budapest, Hungary
SeLENOZYME, a spin-off company based on the research in Elias Arnér's group
Thioredoxin Systems is a spin-off company further developing the antibiotic EbsArgent® originally discovered by Arne Holmgren
Thioredoxin reductase as a potential drug target
Listen to a podcast episode where Prof. Elias Arnér comments on the FRBM special issue "Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases" with Prof. Henry J. Forman.
Selenium: A vital toxin for humans
A rare trace element from the bedrock turned out to be a prerequisite for human life. Since the discovery of selenium 200 years ago, researchers have tried to understand more.